Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice

NCT02847728 · clinicaltrials.gov ↗
COMPLETED
Status
1189
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Bristol-Myers Squibb